[Pulmonary surface activity viewed from the standpoint of internal medicine: pulmonary surfactant and clinical observation in internal medicine].
D000818:Animals; D002245:Carbon Dioxide; D006168:Guinea Pigs; D006801:Humans; D006819:Hyaline Membrane Disease / Q000378:metabolism; D007231:Infant, Newborn; D007565:Jaundice / Q000378:metabolism; D008205:Lymphangitis / Q000378:metabolism; D010100:Oxygen; D010169:Palmitic Acids / Q000378:metabolism; D010713:Phosphatidylcholines / Q000378:metabolism; D011014:Pneumonia / Q000378:metabolism; D011650:Pulmonary Alveoli / Q000378:metabolism*; D001261:Pulmonary Atelectasis / Q000378:metabolism; D011656:Pulmonary Emphysema / Q000378:metabolism; D011663:Pulmonary Surfactants / Q000378:metabolism; D011817:Rabbits; D012965:Sodium Chloride; D013501:Surface-Active Agents / Q000378:metabolism*
D010169:Palmitic Acids; D010713:Phosphatidylcholines; D011663:Pulmonary Surfactants; D013501:Surface-Active Agents; D002245:Carbon Dioxide; D012965:Sodium Chloride; D010100:Oxygen